News | News By Subject | News by Disease News By Date | Search News

News By Date

Get Our FREE
Industry eNewsletter
email:    
News By Date

SuMoTuWeThFrSa
2829301234
567891011
12131415161718
19202122232425
2627282930311
2345678

Friday, July 31, 2015

Top Breaking News

News from Around the Web
Juno (JUNO) CEO: "Can Our Own T-Cells Eat A Solid Tumor? The Answer Is Yes"
The Tale Of Two Teva (TEVA)
From Actavis (ACT) To Allergan (AGN): One Pharma Company's Wild Dealmaking Journey
Why Pharma Must Change Its Model
Another Study Questions The Benefit Of Fish Oil Supplements, University of Pennsylvania Reveals
China Races To Find Its First Blockbuster Drug
First Artificial Ribosome Designed, University of Illinois Researchers Reveal
Infographic Claims To Show What Happens In First Hour After You Drink Coca-Cola
Free Mobile App That Screens For Liver Disease In Newborns Works, Johns Hopkins Children's Center Study
Novel 3D Human Skin Tissue Model Could Help Find Out Why Some Are Allergic To Certain Devices, Applied In Vitro Toxicology Reveals
Can Cognitive Assessment Become A Routine Part Of Checkups?
New Pig Model Will Provide Insights Into Early Detection, Cancer Treatments, University of Illinois Study
This Smart Glove Is Affordable Home Rehab For Stroke Patients, Neofect Reveals

Press Releases
Unichem Pharmaceuticals (USA), Inc. Issues A Voluntary Nationwide Recall Of Hydrochlorothiazide Tablets Due To The Potential Presence Of Foreign Tablets
In Interim Results From Phase III Study, Merck & Co. (MRK)’s Investigational Ebola Vaccine Efficacious; Study Is Continuing
FDA Approves Bayer HealthCare (BAY)'s Finacea (Azelaic Acid) Foam, 15% For The Topical Treatment Of The Inflammatory Papules And Pustules Of Mild To Moderate Rosacea
Bayer HealthCare (BAY) and Foamix Pharmaceuticals, Ltd. (FOMX) Release: Finacea (Azelaic Acid) Foam 15%, Approved By U.S. FDA For Topical Treatment Of The Inflammatory Papules And Pustules Of Mild To Moderate Rosacea
Roche (RHHBY)’s Perjeta Regimen Approved In Europe For Use Before Surgery In Early Stage Aggressive Breast Cancer
ADMA Biologics, Inc. Announces Submission Of RI-002 Biologics License Application (BLA) To FDA
Mundipharma EDO Gmbh Announces FDA Investigational New Drug Approval Of Its First Anti-Cancer Compound, EDO-S101, For The Treatment Of Patients With Relapsed/Refractory Haematologic Malignancies And Solid Tumours
Aratana Therapeutics (PETX) Announces Positive Pilot Field Study For AT-016
NanoSmart Pharmaceuticals, Inc. Receives Second FDA Orphan Drug Designation For Treatment Of Pediatric Cancer
NewLink Genetics (NLNK) Release: Vaccine Candidate Potentially Effective Against Ebola In Large Trial In Guinea
Zai Lab Obtains Global Rights To Sanofi (SNY) NSCLC Drug Candidate
BMG Pharma S.r.l Announces The Signature Of A Distribution Agreement For Its Cancer Supportive Care Line Including Its Iron In Liposomal Technology Based Product With Sayre Therapeutics For India And Other Asian Area Countries
Eisai Inc. (ESALF.PK) And Halozyme (HALO) Sign Collaboration Agreement To Investigate Eribulin And PEGPH20 In Metastatic Breast Cancer
Discovery Laboratories (DSCO) Receives $1.0 Million Under An SBIR Grant In Continuing Support Of The Development Of Aerosolized KL4 Surfactant To Address Radiation-Induced Lung Injury
Insulet (PODD) Reports Preliminary Second Quarter 2015 Revenue Results
MannKind Corporation (MNKD) Triples Production Capacity For Afrezza
Horizon Pharma (HZNP) Announces The U.S. Patent And Trademark Office Issuance Of An Additional Notice Of Allowance With Claims Covering PENNSAID(R) (Diclofenac Sodium Topical Solution) 2%
ZEISS Announces Diffraction Contrast Tomography For 3D Materials Science
China Pharma Holdings, Inc. (CPHI.OB) Received CNY 9.6 Million In Government Subsidies
Cryo-Cell International (CCEL), Cord Blood Banking Company, Announces Final Results Of Its Tender Offer
AMAG (AMAG) Prices Public Offering Of $201 Million Of Common Stock
EyeGate Pharma Announces Pricing Of $10,000,000 Public Offering Of Common Stock And Warrants
Quintiles (Q) Announces Pricing Of Secondary Public Offering
Quintiles (Q) Announces Launch Of Secondary Public Offering Of Common Stock
Change Of The Number Of Shares And Votes In Karo Bio AB
Change In Number Of Shares And Votes In Moberg Pharma AB (Formerly known as Moberg Derma)
Change In The Total Number Of Shares And Votes In Recipharm AB
Number Of Shares And Votes In Orexo AB (ORXOF)
CryoPort, Inc. Provides Cryogenic Logistics Solutions To HemaCare Corp. (HEMA)
Newly Appointed Acting CEO Outlines Immediate Plans For Novogen Limited (NVGN)
Cellecta, Inc. Announces Launch Of Human Whole Genome CRISPR Knockout Library
Tianyin Pharmaceutical Co, Inc. Provides Update Regarding Non-Compliance With NYSE MKT Continued Listing Requirements
BioBridges, LLC And CenterWatch Inc. Announce Insight Series Inaugural Breakfast Meeting
TiGenix: Transparency Information
Amgen (AMGN)'s Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57
Alimera Sciences (ALIM) To Release Second Quarter Fiscal Year 2015 Financial Results
Arena Pharmaceuticals, Inc. (ARNA) To Host Second Quarter 2015 Financial Results And Corporate Update Conference Call And Webcast On Wednesday, August 5
Alnylam (ALNY) To Webcast Conference Call Discussing Second Quarter 2015 Financial Results
Anthera Pharmaceuticals, Inc. (ANTH) To Report 2015 Second Quarter And Operational Update On August 10
Chimerix (CMRX) To Announce Second Quarter 2015 Financial Results On August 6, 2015
Notice Of Cipher Pharma (DND.TO) Q2 2015 Conference Call
Corcept Therapeutics Inc. (CORT) To Announce Second Quarter Financial Results And Corporate Update And Host Conference Call
Enanta Pharmaceuticals, Inc. To Host Conference Call To Discuss Financial Results For The Fiscal Third Quarter And Nine-Months Ended June 30, 2015
EnteroMedics (ETRM) To Host Second Quarter 2015 Financial Results And Company Update Conference Call
Fresenius Kabi AG Raises 2015 Earnings Guidance
Genocea Biosciences To Host Second Quarter 2015 Financial Results Conference Call & Webcast On August 6, 2015
IDEXX Laboratories, Inc. (IDXX) Announces Second Quarter Results
IMS Health Reports Second-Quarter 2015 Results
ImmunoGen (IMGN) Reports Fourth Quarter And Fiscal Year 2015 Financial Results
Ipsen (IPN.PA): 2015 Half-Year Results
Mettler-Toledo (MTD) Reports Second Quarter 2015 Results
NovaBay (NBY) To Hold Second Quarter 2015 Conference Call On August 13
NewLink Genetics (NLNK) Provides Operational Update And Reports Second Quarter 2015 Financial Results
Nektar Therapeutics (NKTR) To Announce Financial Results For The Second Quarter 2015 On Wednesday, August 5, 2015, After Close Of U.S.-Based Financial Markets
Ocata Therapeutics To Host Conference Call And Webcast To Provide Corporate Update For The Second Quarter Of 2015
Oculus Innovative Sciences, Inc. (OCLS) Reports Financial Results For The First Quarter Of Fiscal Year 2016
OncoGenex Pharmaceuticals Inc. (OGXI) To Report Second Quarter 2015 Financial Results On August 13, 2015
Omnicell Announces Second Quarter 2015 Results
PerkinElmer (PKI) Announces Financial Results For The Second Quarter Of 2015
Sanofi (SNY) Delivers Solid Sales And Business EPS Growth In Q2 2015
Synta (SNTA) To Host Conference Call And Webcast Of Second Quarter 2015 Financial Results On August 6, 2015
Seattle Genetics (SGEN) Reports Second Quarter 2015 Financial Results
Takeda (TKPYY) Reports 1st Quarter Results Of FY2015 With Underlying Revenue Growth Of +6.1%
Taro Pharmaceutical Industries Ltd. (TARO) To Announce First Quarter Results On August 6, 2015
Vital Therapies, Inc. (VTI) (VTL) Announces Second Quarter 2015 Financial Results And Provides Corporate Update
SIRO Clinpharm (India) Announces Chief Operating Officer Dr. Vatsal Shah
GenoSpace Introduces Matthew Fischer As Vice President Of Sales And Marketing
Timothy Carlson Named Chief Financial Officer Of Precision
Amgen (AMGN) Announces Appointment Of Fred Hassan To Board Of Directors
Enumeral Biomedical (ENUM) Appoints Robert J. Easton To Its Board Of Directors
Dirk Büscher And José Terencio Resign From TiGenix Board Of Directors
Xencor Appoints Yujiro S. Hata To Board Of Directors
The Tisch Cancer Institute At Icahn School Of Medicine At Mount Sinai Medical Center Earns National Cancer Institute Designation
Sanofi (SNY) H1 2015 Results - Interview With CEO Olivier Brandicourt
IRIS Establishes Napa Meeting To Advance Leading-Edge Directions In Nephrology
AmpliPhi Biosciences Corporation (APHB) To Present Research On Efficacy Of A Novel Bacteriophage Cocktail In S. Aureus Lung Infection Model At ICAAC/ICC 2015
Avinger, Inc. Announces Participation In Canaccord Genuity 35th Annual Growth Conference
Lannett (LCI) To Present At The Canaccord Genuity 35th Annual Growth Conference On August 12
Toshiba Cuts Interim CEO's Pay by 90%
Altura Medical Sold to Lombard Medical (LMT.L) in $50.5 Million Deal
Varian Medical Systems (VAR) Pays $50 Million Cash for Claymount
NuVasive (NUVA) Forks Over $13.5 Million to Settle False Claims Probe
FDA Clears Way For Commercial Marketing Of Sentrian Remote Patient Intelligence Solution
Oxford Finance And Silicon Valley Bank Close $15 Million Debt Facility With AlterG
Genomic Health, Inc. (GHDX) Release: Urology Practice Publishes Study Showing Oncotype DX Increases Use Of Active Surveillance In Prostate Cancer Patients By 56 Percent
ResMed (RMD) Invests In High-Growth Chinese Sleep And Respiratory Care Market With Curative Medical
EBSCO Industries Selects Cardiac Solutions For Its AED Program
Gaumard Scientific's Latest UNI Operating System Update Adds Performance And New Functionality
Nanosphere, Inc. Announces Amendment to $30 Million Term Loan Facility, Release of Q2 2015 Results and Conference Call and Schedules 2015 Annual Meeting of Stockholders
Theranos’ Holmes Marks 50th Anniversary Of Medicare And Medicaid With Vision For Next 50 Years
Precision Biopsy Moves Into New Facility To Ramp Progress While Cultivating Unique Collaboration Between Academia And Industry
Avita Medical l Announces Financial Results And Provides Corporate Update For Fourth Quarter And Fiscal Year 2015
Cardinal Health (CAH) Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results
Globus Medical (GMED) Reports Second Quarter 2015 Results
HeartWare (HTWR) Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth
IRadimed Corporation Announces Second Quarter 2015 Financial Results
MiMedx Announces Record Results For Second Quarter Of 2015
ResMed (RMD) Announces Results For The Fourth Quarter And Fiscal Year 2015
Sigma-Aldrich Corporation (SIAL) (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01
Vermillion To Report Second Quarter 2015 Financial Results And Host Investor Conference Call On August 13
Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results
EOS Imaging Appoints Orthopedics Pioneer Gérard Hascoët As Chairman Of The Board
Edwards Lifesciences (EW) Announces Board Change
Varian Medical Systems (VAR) Awarded Major Tender To Equip Network Of Hospitals In Northwest Spain
TriVascular, Inc. (TRIV) To Present At The Canaccord Genuity Growth Conference
Spectranetics (SPNC) To Present At The Canaccord Genuity Growth Conference
HTG Molecular Diagnostics To Present At The Canaccord Genuity Growth Conference
NanoString (NSTG) To Present At The Canaccord Genuity Growth Conference
EXACT Sciences (EXAS) To Participate In August Conferences
GenMark Diagnostics (GNMK) To Present At The 35th Annual Canaccord Genuity Growth Conference

//-->